Comparable Genital Tract Infection, Pathology, and Immunity in Rhesus Macaques Inoculated with Wild-Type or Plasmid-Deficient Chlamydia trachomatis Serovar D

Infection and Immunity

Volumn 83, Issue 10, 2015, Pages 4056-4067

  Qu, Yanyan ^a   Frazer, Lauren C ^a,b   O'Connell, Catherine M ^a,b   Tarantal, Alice F ^c   Andrews, Charles W ^d   O'Connor, Shelby L ^e   Russell, Ali N ^b   Sullivan, Jeanne E ^b   Poston, Taylor B ^b   Vallejo, Abbe N ^a   Darville, Toni ^a,b  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University Pathologists   (United States)

^e UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BACTERIAL VACCINE; CHLAMYDIA TRACHOMATIS VACCINE; LIVE VACCINE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; BACTERIAL IMMUNITY; BACTERIAL KINETICS; BACTERIAL STRAIN; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; FEMALE GENITAL TRACT INFECTION; FIMBRIA; GENETIC DIFFERENCE; HISTOPATHOLOGY; INFLAMMATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; OVIDUCT; PLASMID; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE; VACCINATION; WILD TYPE; ANIMAL; CD8+ T LYMPHOCYTE; CLASSIFICATION; COMPARATIVE STUDY; GENETICS; GENITAL TRACT INFECTION; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; SEROTYPE;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; FEMALE; HUMANS; MACACA MULATTA; PLASMIDS; REPRODUCTIVE TRACT INFECTIONS; SEROGROUP;

EID: 84944463303     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00841-15     Document Type: Article

References (38)

1. ResnikoffS, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, Mariotti SP. 2004. Global data on visual impairment in the year 2002. Bull World Health Organ 82:844-851.
2. Rekart ML, Gilbert M, Meza R, Kim PH, Chang M, Money DM, Brunham RC. 2013. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis 207:30-38. http://dx.doi.org/10.1093/infdis/jis644.
3. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. 2010. Risk of sequelae after Chlamydia trachomatis genital infection in women. J Infect Dis 201(Suppl 2):S134-S155. http://dx.doi.org/10.1086/652395.
4. Darville T, Hiltke TJ. 2010. Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 201(Suppl 2):S114-S125.
5. O'Connell CM, Ingalls RR, Andrews CW, Jr, Skurlock AM, Darville T. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 179:4027-4034. http://dx.doi.org/10.4049/jimmunol.179.6.4027.
6. Russell M, Darville T, Chandra-Kuntal K, Smith B, Andrews CW, Jr, O'Connell CM. 2011. Infectivity acts as in vivo selection for maintenance of the chlamydial cryptic plasmid. Infect Immun 79:98-107. http://dx.doi.org/10.1128/IAI.01105-10.
7. Kari L, Whitmire WM, Olivares-Zavaleta N, Goheen MM, Taylor LD, Carlson JH, Sturdevant GL, Lu C, Bakios LE, Randall LB, Parnell MJ, Zhong G, Caldwell HD. 2011. A live-attenuated chlamydial vaccine protects against trachoma in nonhuman primates. J Exp Med 208:2217-2223. http://dx.doi.org/10.1084/jem.20111266.
8. Sigar IM, Schripsema JH, Wang Y, Clarke IN, Cutcliffe LT, Seth-Smith HM, Thomson NR, Bjartling C, Unemo M, Persson K, Ramsey KH. Plasmid deficiency in urogenital isolates of Chlamydia trachomatis reduces infectivity and virulence in a mouse model. Pathog Dis 70:61-69. http://dx.doi.org/10.1111/2049-632X.12086.
9. Riley MM, Zurenski MA, Frazer LC, O'Connell CM, Andrews CW, Jr, Mintus M, Darville T. 2012. The recall response induced by genital challenge with Chlamydia muridarum protects the oviduct from pathology but not from reinfection. Infect Immun 80:2194-2203. http://dx.doi.org/10.1128/IAI.00169-12.
10. Frazer LC, Darville T, Chandra-Kuntal K, Andrews CW, Jr, Zurenski M, Mintus M, AbdelRahman YM, Belland RJ, Ingalls RR, O'Connell CM. 2012. Plasmid-cured Chlamydia caviae activates TLR2-dependent signaling and retains virulence in the guinea pig model of genital tract infection. PLoS One 7:e30747. http://dx.doi.org/10.1371/journal.pone.0030747.
11. Miyairi I, Laxton JD, Wang X, Obert CA, Arva Tatireddigari VR, van Rooijen N, Hatch TP, Byrne GI. 2011. Chlamydia psittaci genetic variants differ in virulence by modulation of host immunity. J Infect Dis 204:654-663. http://dx.doi.org/10.1093/infdis/jir333.
12. Abdelsamed H, Peters J, Byrne GI. 2013. Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. Future Microbiol 8:1129-1146. http://dx.doi.org/10.2217/fmb.13.80.
13. Caldwell HD, Wood H, Crane D, Bailey R, Jones RB, Mabey D, Maclean I, Mohammed Z, Peeling R, Roshick C, Schachter J, Solomon AW, Stamm WE, Suchland RJ, Taylor L, West SK, Quinn TC, Belland RJ, McClarty G. 2003. Polymorphisms in Chlamydia trachomatis tryptophan synthase genes differentiate between genital and ocular isolates. J Clin Invest 111:1757-1769. http://dx.doi.org/10.1172/JCI17993.
14. Fehlner-Gardiner C, Roshick C, Carlson JH, Hughes S, Belland RJ, Caldwell HD, McClarty G. 2002. Molecular basis defining human Chlamydia trachomatis tissue tropism. A possible role for tryptophan synthase. J Biol Chem 277:26893-26903.
15. Nelson DE, Virok DP, Wood H, Roshick C, Johnson RM, Whitmire WM, Crane DD, Steele-Mortimer O, Kari L, McClarty G, Caldwell HD. Chlamydial IFN-gamma immune evasion is linked to host infection tropism. Proc Natl Acad Sci U S A 102:10658-10663. http://dx.doi.org/10.1073/pnas.0504198102.
16. Roshick C, Wood H, Caldwell HD, McClarty G. 2006. Comparison of gamma interferon-mediated antichlamydial defense mechanisms in human and mouse cells. Infect Immun 74:225-238. http://dx.doi.org/10.1128/IAI.74.1.225-238.2006.
17. O'Connell CM, AbdelRahman YM, Green E, Darville HK, Saira K, Smith B, Darville T, Scurlock AM, Meyer CR, Belland RJ. 2011. Tolllike receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun 79:1044-1056. http://dx.doi.org/10.1128/IAI.01118-10.
18. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754-759. http://dx.doi.org/10.1126/science.282.5389.754.
19. O'Connell CM, Nicks KM. 2006. A plasmid-cured Chlamydia muridarum strain displays altered plaque morphology and reduced infectivity in cell culture. Microbiology 152:1601-1607. http://dx.doi.org/10.1099/mic.0.28658-0.
20. Kelly KA, Robinson EA, Rank RG. 1996. Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. Infect Immun 64:4976-4983. (Erratum, 65:2508, 1997.).
21. He X, Nair A, Mekasha S, Alroy J, O'Connell CM, Ingalls RR. 2011. Enhanced virulence of Chlamydia muridarum respiratory infections in the absence of TLR2 activation. PLoS One 6:e20846. http://dx.doi.org/10.1371/journal.pone.0020846.
22. Darville T, Andrews CW, Jr, Laffoon KK, Shymasani W, Kishen LR, Rank RG. 1997. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response. Infect Immun 65:3065-3073.
23. Bom RJ, Christerson L, Schim van der LoeffMF, Coutinho RA, Herrmann B, Bruisten SM. 2011. Evaluation of high-resolution typing methods for Chlamydia trachomatis in samples from heterosexual couples. J Clin Microbiol 49:2844-2853. http://dx.doi.org/10.1128/JCM.00128-11.
24. Scurlock AM, Frazer LC, Andrews CW, Jr, O'Connell CM, Foote IP, Bailey SL, Chandra-Kuntal K, Kolls JK, Darville T. 2011. Interleukin-17 contributes to generation of Th1 immunity and neutrophil recruitment during Chlamydia muridarum genital tract infection but is not requiredfor macrophage influx or normal resolution of infection. Infect Immun 79:1349-1362. http://dx.doi.org/10.1128/IAI.00984-10.
25. Wiseman RW, Karl JA, Bimber BN, O'Leary CE, Lank SM, Tuscher JJ, Detmer AM, Bouffard P, Levenkova N, Turcotte CL, Szekeres E, Jr, Wright C, Harkins T, O'Connor DH. 2009. Major histocompatibility complex genotyping with massively parallel pyrosequencing. Nat Med 15:1322-1326. http://dx.doi.org/10.1038/nm.2038.
26. Patton DL, Sweeney YT, Stamm WE. 2005. Significant reduction in inflammatory response in the macaque model of chlamydial pelvic inflammatory disease with azithromycin treatment. J Infect Dis 192:129-135 http://dx.doi.org/10.1086/431365.
27. SoloffAC, Liu X, Gao W, Day RD, Gambotto A, Barratt-Boyes SM. Adenovirus 5-and 35-based immunotherapy enhances the strength but not breadth or quality of immunity during chronic SIV infection. Eur J Immunol 39:2437-2449. http://dx.doi.org/10.1002/eji.200839130.
28. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, Maino VC, Axthelm MK, Picker LJ. 2002. Development and homeostasis of T cell memory in rhesus macaque. J Immunol 168:29-43. http://dx.doi.org/10.4049/jimmunol.168.1.29.
29. Carlson JH, Whitmire WM, Crane DD, Wicke L, Virtaneva K, Sturdevant DE, Kupko JJ, III, Porcella SF, Martinez-Orengo N, Heinzen RA, Kari L, Caldwell HD. 2008. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun 76:2273-2283. http://dx.doi.org/10.1128/IAI.00102-08.
30. Wolner-Hanssen P, Patton DL, Holmes KK. 1991. Protective immunity in pig-tailed macaques after cervical infection with Chlamydia trachomatis. Sex Transm Dis 18:21-25. http://dx.doi.org/10.1097/00007435-199101000-00005.
31. Patton DL, Kuo CC, Wang SP, Halbert SA. 1987. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingeal infections in pig-tailed macaques. J Infect Dis 155:1292-1299. http://dx.doi.org/10.1093/infdis/155.6.1292.
32. Lichtenwalner AB, Patton DL, Cosgrove Sweeney YT, Gaur LK, Stamm WE. 1997. Evidence of genetic susceptibility to Chlamydia trachomatisinduced pelvic inflammatory disease in the pig-tailed macaque. Infect Immun 65:2250-2253.
33. Iijima N, Iwasaki A. 2014. T cell memory. A local macrophage chemokine network sustains protective tissue-resident memory CD4 T cells. Science 346:93-98. http://dx.doi.org/10.1126/science.1257530.
34. Oakeshott P, Kerry S, Aghaizu A, Atherton H, Hay S, Taylor-Robinson D, Simms I, Hay P. 2010. Randomised controlled trial of screening for Chlamydia trachomatis to prevent pelvic inflammatory disease: the POPI (prevention of pelvic infection) trial. Br Med J 340:c1642. http://dx.doi.org/10.1136/bmj.c1642.
35. Geisler WM, Suchland RJ, Whittington WL, Stamm WE. 2001. Quantitative culture of Chlamydia trachomatis: relationship of inclusionforming units produced in culture to clinical manifestations and acute inflammation in urogenital disease. J Infect Dis 184:1350-1354. http://dx.doi.org/10.1086/323998.
36. Molano M, Meijer CJ, Weiderpass E, Arslan A, Posso H, Franceschi S, Ronderos M, Munoz N, van den Brule AJ. 2005. The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 191:907-916. http://dx.doi.org/10.1086/428287.
37. Geisler WM. 2010. Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with chlamydia resolution: a review of human studies. J Infect Dis 201(Suppl 2):S104-S113. http://dx.doi.org/10.1086/652402.
38. Stary G, Olive A, Radovic-Moreno AF, Gondek D, Alvarez D, Basto PA, Perro M, Vrbanac VD, Tager AM, Shi J, Yethon JA, Farokhzad OC, Langer R, Starnbach MN, von Andrian UH. 2015. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. Science 348:aaa8205. http://dx.doi.org/10.1126/science.aaa8205.